• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

表面活性剂对塞来昔布无定形固体分散体喷雾干燥颗粒水悬浮液结晶的影响。

Impact of surfactants on the crystallization of aqueous suspensions of celecoxib amorphous solid dispersion spray dried particles.

作者信息

Chen Jie, Ormes James D, Higgins John D, Taylor Lynne S

机构信息

Department of Industrial and Physical Pharmacy, College of Pharmacy, Purdue University , West Lafayette, Indiana 47907, United States.

出版信息

Mol Pharm. 2015 Feb 2;12(2):533-41. doi: 10.1021/mp5006245. Epub 2015 Jan 22.

DOI:10.1021/mp5006245
PMID:25569461
Abstract

Amorphous solid dispersions are frequently prepared by spray drying. It is important that the resultant spray dried particles do not crystallize during formulation, storage, and upon administration. The goal of the current study was to evaluate the impact of surfactants on the crystallization of celecoxib amorphous solid dispersions (ASD), suspended in aqueous media. Solid dispersions of celecoxib with hydroxypropylmethylcellulose acetate succinate were manufactured by spray drying, and aqueous suspensions were prepared by adding the particles to acidified media containing various surfactants. Nucleation induction times were evaluated for celecoxib in the presence and absence of surfactants. The impact of the surfactants on drug and polymer leaching from the solid dispersion particles was also evaluated. Sodium dodecyl sulfate and Polysorbate 80 were found to promote crystallization from the ASD suspensions, while other surfactants including sodium taurocholate and Triton X100 were found to inhibit crystallization. The promotion or inhibition of crystallization was found to be related to the impact of the surfactant on the nucleation behavior of celecoxib, as well as the tendency to promote leaching of the drug from the ASD particle into the suspending medium. It was concluded that surfactant choice is critical to avoid failure of amorphous solid dispersions through crystallization of the drug.

摘要

无定形固体分散体通常通过喷雾干燥制备。重要的是,所得喷雾干燥颗粒在制剂、储存和给药过程中不会结晶。本研究的目的是评估表面活性剂对悬浮在水性介质中的塞来昔布无定形固体分散体(ASD)结晶的影响。通过喷雾干燥制备塞来昔布与醋酸羟丙甲纤维素琥珀酸酯的固体分散体,并通过将颗粒加入含有各种表面活性剂的酸化介质中来制备水性悬浮液。评估了在有和没有表面活性剂的情况下塞来昔布的成核诱导时间。还评估了表面活性剂对固体分散体颗粒中药物和聚合物浸出的影响。发现十二烷基硫酸钠和聚山梨酯80可促进ASD悬浮液中的结晶,而其他表面活性剂,包括牛磺胆酸钠和曲拉通X100,则可抑制结晶。发现结晶的促进或抑制与表面活性剂对塞来昔布成核行为的影响以及促进药物从ASD颗粒浸出到悬浮介质中的趋势有关。得出的结论是,表面活性剂的选择对于避免无定形固体分散体因药物结晶而失效至关重要。

相似文献

1
Impact of surfactants on the crystallization of aqueous suspensions of celecoxib amorphous solid dispersion spray dried particles.表面活性剂对塞来昔布无定形固体分散体喷雾干燥颗粒水悬浮液结晶的影响。
Mol Pharm. 2015 Feb 2;12(2):533-41. doi: 10.1021/mp5006245. Epub 2015 Jan 22.
2
Leaching of Lopinavir Amorphous Solid Dispersions in Acidic Media.洛匹那韦无定形固体分散体在酸性介质中的溶出
Pharm Res. 2016 Jul;33(7):1723-35. doi: 10.1007/s11095-016-1913-5. Epub 2016 Mar 29.
3
Investigation into the Solid-State Properties and Dissolution Profile of Spray-Dried Ternary Amorphous Solid Dispersions: A Rational Step toward the Design and Development of a Multicomponent Amorphous System.喷雾干燥三元无定形固体分散体的固态特性和溶出特性研究:多组分无定形系统设计和开发的合理步骤。
Mol Pharm. 2018 Sep 4;15(9):3796-3812. doi: 10.1021/acs.molpharmaceut.8b00306. Epub 2018 Jul 30.
4
Impact of surfactants on the crystal growth of amorphous celecoxib.表面活性剂对无定形塞来昔布晶体生长的影响。
Int J Pharm. 2014 Jan 30;461(1-2):251-7. doi: 10.1016/j.ijpharm.2013.11.057. Epub 2013 Dec 9.
5
Atypical effects of incorporated surfactants on stability and dissolution properties of amorphous polymeric dispersions.掺入的表面活性剂对无定形聚合物分散体稳定性和溶解性能的非典型影响。
J Pharm Pharmacol. 2016 Nov;68(11):1373-1383. doi: 10.1111/jphp.12645. Epub 2016 Oct 2.
6
Dissolution Performance of High Drug Loading Celecoxib Amorphous Solid Dispersions Formulated with Polymer Combinations.采用聚合物组合制备的高载药量塞来昔布无定形固体分散体的溶出性能
Pharm Res. 2016 Mar;33(3):739-50. doi: 10.1007/s11095-015-1823-y. Epub 2015 Nov 12.
7
Hybrid nanocrystal-amorphous solid dispersions (HyNASDs) as alternative to ASDs for enhanced release of BCS Class II drugs.用于增强 BCS 类 II 药物释放的混合纳米晶-无定形固体分散体(HyNASDs)替代 ASDs。
Eur J Pharm Biopharm. 2019 Dec;145:12-26. doi: 10.1016/j.ejpb.2019.10.002. Epub 2019 Oct 14.
8
Improved Release of Celecoxib from High Drug Loading Amorphous Solid Dispersions Formulated with Polyacrylic Acid and Cellulose Derivatives.由聚丙烯酸和纤维素衍生物配制的高载药量非晶态固体分散体中塞来昔布的释放改善
Mol Pharm. 2016 Mar 7;13(3):873-84. doi: 10.1021/acs.molpharmaceut.5b00798. Epub 2016 Feb 2.
9
Impact of Surfactant and Surfactant-Polymer Interaction on Desupersaturation of Clotrimazole.表面活性剂和表面活性剂-聚合物相互作用对克霉唑去超饱和度的影响。
J Pharm Sci. 2019 Oct;108(10):3262-3271. doi: 10.1016/j.xphs.2019.05.035. Epub 2019 Jun 14.
10
Role of Surfactants on Release Performance of Amorphous Solid Dispersions of Ritonavir and Copovidone.表面活性剂对利托那韦无定形固体分散体和共聚维酮释放性能的作用。
Pharm Res. 2022 Feb;39(2):381-397. doi: 10.1007/s11095-022-03183-4. Epub 2022 Feb 15.

引用本文的文献

1
Amorphous Solid Dispersions of Glycyrrhetinic Acid: Using Soluplus, PVP, and PVPVA as the Polymer Matrix to Enhance Solubility, Bioavailability, and Stability.甘草次酸的无定形固体分散体:使用聚乙烯己内酰胺-聚乙酸乙烯酯-聚乙二醇接枝共聚物(Soluplus)、聚乙烯吡咯烷酮(PVP)和聚乙烯吡咯烷酮-醋酸乙烯酯共聚物(PVPVA)作为聚合物基质来提高溶解度、生物利用度和稳定性。
AAPS PharmSciTech. 2024 Dec 21;26(1):18. doi: 10.1208/s12249-024-03007-1.
2
Multivariate Analysis of Solubility Parameters for Drug-Polymer Miscibility Assessment in Preparing Raloxifene Hydrochloride Amorphous Solid Dispersions.多变量分析溶解度参数评估盐酸雷洛昔芬制备无定形固体分散体中药物-聚合物的相容性。
AAPS PharmSciTech. 2024 Jun 6;25(5):127. doi: 10.1208/s12249-024-02844-4.
3
The Development of an Oral Solution Containing Nirmatrelvir and Ritonavir and Assessment of Its Pharmacokinetics and Stability.
含奈玛特韦和利托那韦口服溶液的研发及其药代动力学和稳定性评估。
Pharmaceutics. 2024 Jan 14;16(1):109. doi: 10.3390/pharmaceutics16010109.
4
Effects of Additives on the Physical Stability and Dissolution of Polymeric Amorphous Solid Dispersions: a Review.添加剂对聚合物无定形固体分散体物理稳定性和溶解性能的影响:综述。
AAPS PharmSciTech. 2023 Aug 21;24(7):175. doi: 10.1208/s12249-023-02622-8.
5
Fed- and Fasted-State Performance of Pretomanid Amorphous Solid Dispersions Formulated with an Enteric Polymer.依托肠溶性聚合物的pretomanid 无定形固体分散体的进食和禁食状态性能。
Mol Pharm. 2023 Jun 5;20(6):3170-3186. doi: 10.1021/acs.molpharmaceut.3c00174. Epub 2023 May 23.
6
Release Enhancement by Plasticizer Inclusion for Amorphous Solid Dispersions Containing High T Drugs.增塑剂包合提高高 Tg 药物无定形固体分散体的释放度。
Pharm Res. 2023 Mar;40(3):777-790. doi: 10.1007/s11095-023-03483-3. Epub 2023 Mar 1.
7
Hydrating Capabilities of the Biopolymers Produced by the Marine Thermophilic SBP3 as Evaluated by ATR-FTIR Spectroscopy.通过衰减全反射傅里叶变换红外光谱(ATR-FTIR)评估海洋嗜热菌SBP3产生的生物聚合物的水合能力。
Materials (Basel). 2022 Aug 30;15(17):5988. doi: 10.3390/ma15175988.
8
Physicochemical and Biochemical Evaluation of Amorphous Solid Dispersion of Naringenin Prepared Using Hot-Melt Extrusion.采用热熔挤出法制备的柚皮苷无定形固体分散体的物理化学和生化评价
Front Nutr. 2022 Apr 27;9:850103. doi: 10.3389/fnut.2022.850103. eCollection 2022.
9
Examination of dissolution ratio of β-carotene in water for practical application of β-carotene amorphous solid dispersion.考察β-胡萝卜素无定形固体分散体实际应用中β-胡萝卜素在水中的溶出率。
J Food Sci Technol. 2022 Jan;59(1):114-122. doi: 10.1007/s13197-021-04991-z. Epub 2021 Feb 1.
10
Impact of Surfactants on the Performance of Clopidogrel-Copovidone Amorphous Solid Dispersions: Increased Drug Loading and Stabilization of Nanodroplets.表面活性剂对氯吡格雷-共聚维酮无定形固体分散体性能的影响:提高载药量和纳米液滴的稳定性。
Pharm Res. 2022 Jan;39(1):167-188. doi: 10.1007/s11095-021-03159-w. Epub 2022 Jan 10.